×
AbbVie Revenue 2010-2024 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AbbVie revenue for the twelve months ending June 30, 2024 was
$55.000B
, a
1.83% decline
year-over-year.
AbbVie annual revenue for 2023 was
$54.318B
, a
6.44% decline
from 2022.
AbbVie annual revenue for 2022 was
$58.054B
, a
3.3% increase
from 2021.
AbbVie annual revenue for 2021 was
$56.197B
, a
22.69% increase
from 2020.
View More
AbbVie Revenue 2010-2024 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AbbVie annual revenue for 2023 was
$54.318B
, a
6.44% decline
from 2022.
AbbVie annual revenue for 2022 was
$58.054B
, a
3.3% increase
from 2021.
AbbVie annual revenue for 2021 was
$56.197B
, a
22.69% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$861.3B
Novo Nordisk (NVO)
$592.4B
Johnson & Johnson (JNJ)
$402.2B
Merck (MRK)
$299.6B
AstraZeneca (AZN)
$243.5B
Novartis AG (NVS)
$236.5B
Pfizer (PFE)
$169B
Sanofi (SNY)
$144.1B
Innoviva (INVA)
$1.2B